Palo Alto Networks Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Palo Alto Networks Inc trades at $400.3 (market cap $331.76B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B). The key difference: Palo Alto Networks Inc is far larger — about 13.2× Roivant Sciences Ltd. Common Shares's market cap, and Palo Alto Networks Inc is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Palo Alto Networks Inc for 82 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| PANW | ROIV | |
|---|---|---|
Market Cap | $331.76B | $25.09B |
Volume | 3,886,927 | 5,738,571 |
Sector | Technology | Health |
52-Week High | $419.91 | $41.81 |
52-Week Low | $141.67 | $16.04 |
Typical Hold Time | 82 Days | 0 Days |
Enterprise Value | $331.19B | $21.36B |
Signals from Pluang's Aura AI — not financial advice
Palo Alto Networks (PANW) trades at $398.50, down 5.1% today but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive analyst sentiment (72% buy ratings). Recent earnings beats and robust revenue growth to $9.22B in 2025 highlight fundamental strength, though valuation metrics appear elevated with P/E at 1,013.93 and P/S at 26.99. The company's AI-driven security platform and continuous defense services are driving market optimism.
Outlook remains positive given cybersecurity demand and AI integration, but premium valuation and rising costs pose risks. Revenue growth acceleration to $11.5B projected for 2026 supports bullish case, while net margin compression to 2.67% warrants monitoring. Analyst consensus target of $398.70 suggests limited near-term upside from current levels.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →